Prostate cancer is one of the most commonly diagnosed cancers in men, especially those over the age of 50. While the diagnosis can be overwhelming, timely treatment can lead to excellent outcomes, particularly when the cancer is caught early. The encouraging news for patients is that high-quality prostate cancer treatment is not only accessible but also affordable in India.
The cost of prostate cancer treatment in India typically ranges from ₹3,50,000 ($4,200) to ₹9,00,000 ($10,800) or more, depending on the type and stage of the cancer, the chosen treatment, and the hospital facility. It is significantly lower than what patients would pay in countries such as the United States, the United Kingdom, or the UAE without compromising on care quality or technology.
India offers advanced options such as robotic-assisted prostatectomy, intensity-modulated radiation therapy (IMRT), hormone therapy, and cutting-edge immunotherapy, Lutetium-177 PSMA therapy, all under the supervision of internationally trained oncologists and urologists. With its combination of medical expertise, advanced infrastructure, and affordable pricing, India has become a top destination for prostate cancer treatment for patients from Africa, the Middle East, Europe, and beyond.
Prostate cancer is a type of cancer that develops in the prostate (a small, walnut-shaped gland in the male reproductive system that produces seminal fluid). The prostate gland sits just below the bladder and neighbours the urethra, the tube through which urine and semen pass. Prostate cancer usually grows slowly and may not cause serious harm in its early stages. However, there are a few forms of prostate cancer that can be aggressive and spread quickly if left untreated.
Prostate cancer often begins when abnormal cells in the prostate start multiplying uncontrollably. With time, these cells can form a tumor and potentially spread to nearby tissues or even distant parts of the body, such as the bones and lymph nodes.
While not all prostate cancers behave the same way, understanding the different types helps determine the best treatment path. Some of the most common types are:
Prostate cancer often develops quietly, especially in its early stages. Many men may not notice any symptoms until the cancer has grown large enough to affect the surrounding tissues or organs. That's why regular health checks are so necessary, particularly for men over 50.
However, when symptoms do appear, they usually relate to changes in urination or sexual function. Paying attention to early warning signs leads to quicker prostate cancer diagnosis and better treatment outcomes.
The most common symptoms men might experience are:
Keep in mind that these symptoms can also occur due to non-cancerous conditions like an enlarged prostate or infections. But if they persist or worsen over time, it's crucial to consult a doctor.
Treatment for prostate cancer is not one-size-fits-all. The right plan depends on factors like the stage of cancer, how fast it's growing, your age, overall health, and personal preferences. Some men may need aggressive treatment right away, while others can take a more gradual approach with regular monitoring.
The main treatment options available for prostate cancer are:
Surgery is often recommended when the cancer is still confined to the prostate. The most common type is a radical prostatectomy, where the entire prostate gland is removed. It can be achieved through traditional open surgery or more advanced robotic-assisted techniques, which enable greater precision and a quicker recovery.
Surgery aims to eradicate the cancer, but it may cause side effects like urinary incontinence or erectile dysfunction. However, with skilled surgeons and better techniques, many men regain normal function over time.
Radiation uses high-energy beams or rays to target and kill cancer cells. It's often used as a primary treatment or after surgery if there's a risk the cancer might return. There are different types of radiation:
Modern techniques, such as IMRT (Intensity-Modulated Radiation Therapy) and SBRT (Stereotactic Body Radiation Therapy), help protect surrounding healthy tissue while effectively treating the cancer.
Also known as androgen deprivation therapy, this treatment lowers levels of male hormones like testosterone, which fuel prostate cancer growth. Hormone therapy can shrink the tumor or slow its progress, especially in advanced or high-risk cases.
Hormone therapy treatment doesn't cure cancer on its own, but it's often used along with radiation or chemotherapy to improve results.
Chemotherapy is usually reserved for aggressive or metastatic prostate cancers that don't respond well to hormone therapy. It uses potent drugs to attack rapidly dividing cancer cells throughout the body. It's given in cycles and may be used to shrink tumors, ease symptoms, or extend survival.
Commonly used drugs include docetaxel and cabazitaxel, which are effective even in advanced stages.
Targeted therapy focuses on specific genetic mutations or proteins that enable cancer cells to grow. One example is PARP inhibitors, which may be prescribed to men with BRCA1 or BRCA2 gene mutations. These drugs can slow disease progression and improve outcomes for selected patients.
This newer approach uses the body's own immune system to fight cancer. While not suitable for everyone, certain types of immunotherapy (such as checkpoint inhibitors) are being studied and used in advanced cases, especially when other treatments have failed.
Lu-177 PSMA therapy is an advanced treatment used for metastatic prostate cancer that does not respond to traditional therapies. It combines a radioactive isotope (Lu-177) with a molecule that targets the prostate-specific membrane antigen (PSMA), which is a protein found on the surface of prostate cancer cells. Once attached, it delivers radiation directly to the tumor while sparing healthy tissue. This therapy is showing promise in improving both survival and quality of life in patients with late-stage disease.
In cases where the prostate cancer is slow-growing and not causing symptoms, doctors may recommend a "watch and wait" approach. Regular checkups, PSA tests, and biopsies are done to monitor the cancer. If it starts to grow or change, treatment can begin.
This option helps avoid unnecessary side effects in men whose cancer may never become life-threatening.
One of the significant reasons international patients choose India for prostate cancer treatment is the cost advantage. Patients receive world-class care at a fraction of what they would pay in countries like the United States, the UK, or Australia, without compromising on quality, technology, or medical expertise.
The cost of prostate cancer treatment in India typically ranges from ₹3,50,000 (approximately $4,200) to ₹9,00,000 ($10,800) or more, depending on the treatment type, hospital, city, and stage of the disease.
Below is the breakdown of the average cost range for each treatment modality:
One of the many reasons patients travel abroad for prostate cancer care is the high cost of treatment in their home countries. India stands out for delivering globally comparable quality at a fraction of the price. Here's a side-by-side look at how much common prostate cancer treatments cost across different countries:
The total cost of treating prostate cancer can vary significantly from one patient to another. This variation is due to a mix of clinical, logistical, and personal factors that influence how the treatment is planned and delivered. Here's a closer look at what impacts the final cost:
India has become a trusted destination for prostate cancer treatment among international patients, not just for its affordability but for the comprehensive care, personalized attention, and advanced technologies available. Here's what makes the country a preferred option for thousands of patients each year:
Hospitals across India follow a structured, evidence-based approach to treating prostate cancer. The goal is to design a personalized treatment plan that matches the patient's specific cancer type, stage, and health profile, while minimizing side effects and maximizing the desired results. From the initial consultation to post-treatment care, every step is carefully coordinated and managed.
The process begins with a detailed evaluation of your medical history, symptoms, and test results. A PSA (Prostate-Specific Antigen) test, digital rectal exam (DRE), MRI, and prostate biopsy are usually performed to confirm the diagnosis of prostate cancer and determine its aggressiveness.
Once the Gleason score and cancer stage are identified, a multidisciplinary team of specialists reviews the findings to map out the best course of action.
Before starting treatment, doctors assess whether the cancer is localized (within the prostate), locally advanced, or has spread to other areas like bones or lymph nodes. Bone scans and PET-CT imaging can provide a more precise understanding of the disease's spread.
This staging plays a key role in choosing between surgery, radiation, hormone therapy, or combinations.
Based on the stage and type of cancer, one or more treatment strategies are selected:
For patients with slow-growing tumors, active surveillance is sometimes advised to avoid unnecessary side effects.
Here's how different treatments are typically administered:
Treatment is often combined in phases to enhance results—for example, radiation may be followed by hormone therapy to reduce recurrence.
After the primary treatment is complete, regular PSA testing, imaging scans, and follow-up visits help doctors track your recovery and detect any signs of recurrence early. Many hospitals also offer remote follow-up support for international patients, making long-term care more convenient and accessible.
The success of prostate cancer treatment in India has steadily improved over the years thanks to better diagnostic tools, advanced technology, and personalized treatment strategies. Whether the cancer is caught early or has already advanced, Indian oncologists follow globally accepted protocols that aim for the best possible outcomes.
For patients diagnosed at an early stage (localized prostate cancer), the treatment success rate is very high. With timely surgery or radiation therapy, 5-year survival rates can exceed 95%, and in many cases, patients return to a completely normal life.
Advanced tools like robot-assisted surgery and image-guided radiation help reduce complications and improve long-term control over the disease.
Even in cases where cancer has spread beyond the prostate, outcomes have become much more promising. Treatments such as hormone therapy, chemotherapy, and Lu-177 PSMA therapy have significantly improved symptom control, slowed disease progression, and extended life expectancy.
Patients with metastatic prostate cancer undergoing Lu-177 therapy in India have shown improved overall survival of 12–18 months or more, with better quality of life and reduced pain.
"When I was diagnosed with advanced prostate cancer, I was overwhelmed by the treatment costs in my home country. A friend recommended India, and I came across Dr. Ankur Bahl at Fortis Gurgaon. From the first virtual consultation to the final dose of Lu-177 therapy, everything was smooth, transparent, and handled with care. Today, my PSA levels have dropped significantly, and I feel like myself again."
"I chose Fortis Gurgaon for my prostate surgery under Dr. Bahl's care. What stood out to me was the personal attention I received. Dr. Bahl explained every step in detail, and the robotic surgery went smoothly. I started walking the next day and was discharged within 3 days. The whole experience was far better than I had expected."
"My father underwent radiation and hormone therapy under Dr. Ankur Bahl's guidance at Fortis Gurgaon. The cost was nearly 70% less than what we were quoted back home. More importantly, the care was exceptional. We had a dedicated case manager, translator, and everything was arranged before we even landed. He's now back home and doing well."
"After exhausting options in my country, I was introduced to Lu-177 PSMA therapy in India. Dr. Bahl and the nuclear medicine team at Fortis Gurgaon explained everything clearly and thoroughly. After three sessions, my symptoms improved drastically, and my scans showed a major response. I can't thank them enough for this renewed hope."
Yes, prostate cancer is highly curable when diagnosed in the early stages. With timely surgery or radiation, most patients achieve complete remission and can lead a normal, healthy life.
The cost typically ranges from ₹3,50,000 to ₹9,00,000 ($4,200 – $10,800) depending on the treatment type, hospital, and stage of cancer. Advanced treatments, such as Lu-177 therapy, are on the higher end of this range.
For surgery or radiation therapy, a stay of 2–3 weeks is usually enough. If you're undergoing chemotherapy or Lu-177 therapy, your stay may extend over multiple visits. Hospitals often help with travel planning and accommodation.
Yes, Lu-177 PSMA therapy has shown auspicious results in patients with metastatic or treatment-resistant prostate cancer. It can significantly reduce tumor burden, improve symptoms, and extend survival with minimal side effects.
Absolutely. Doctors like Dr. Ankur Bahl and institutions such as Fortis Gurgaon treat thousands of international patients each year. They follow global treatment standards and are well-versed in handling complex prostate cancer cases.
No, most medical professionals speak fluent English. Additionally, major hospitals offer interpreters for Arabic, French, Swahili, and other languages to ensure seamless communication.
Patients will need a valid passport, a medical visa (which can be easily arranged with hospital support), recent medical reports, and imaging scans, such as PSA levels or biopsy results.
Yes. Many hospitals offer online consultations with specialists before your arrival. After treatment, follow-up can also be done virtually to save travel costs and maintain continuity of care.
Most hospitals in India offer package pricing that includes doctors' fees, room charges, medications, and standard diagnostic tests. However, additional tests, extended stays, or complications may add to the final bill. It's best to confirm the cost estimate with the hospital.
Some hospitals in India accept international insurance, especially if your provider is part of a global insurance network. However, cash payments are more commonly expected, and you may need to seek reimbursement from your insurance provider afterward. Always check with both your insurer and the hospital in advance.
Hospitals accept payments via bank transfer, credit/debit cards, wire transfer, and a limited amount of cash (in Indian Rupees or US Dollars).